Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
43,299,548
-
Share change
-
+4,963,515
-
Total reported value
-
$5,683,596,624
-
Put/Call ratio
-
157%
-
Price per share
-
$131.29
-
Number of holders
-
883
-
Value change
-
+$657,483,349
-
Number of buys
-
336
-
Number of sells
-
318
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2022
As of 31 Dec 2022,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
883 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,299,548 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, Royal Bank of Canada, CITIGROUP INC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, UBS Group AG, Caxton Associates LP, JANE STREET GROUP, LLC, and WELLS FARGO & COMPANY/MN.
This page lists
894
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.